PEAK6 Group’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
$712K Sell
11,900
-15,000
-56% -$807K ﹤0.01% 2274
2018
Q1
$1.08M Hold
26,900
﹤0.01% 1884
2017
Q4
$1.41M Buy
26,900
+23,400
+669% +$1.25M 0.01% 1660
2017
Q3
$165K Hold
3,500
﹤0.01% 3448
2017
Q2
$124K Buy
+3,500
New +$108K ﹤0.01% 3719
2016
Q3
Sell
-25,000
Closed -$306K 4399
2016
Q2
$306K Buy
+25,000
New +$188K ﹤0.01% 2797

Other funds holding EXAS

PEAK6 Group's EXAS Position: Q2 2018 in Review

PEAK6 Group sold out of Exact Sciences (EXAS) in Q2 2018, closing a stake of 16,985 shares — an estimated $914K sold.

PEAK6 Group first reported a position in EXAS in Q4 2017 and held it in 2 quarters. The position peaked at $685K in Q1 2018. 348 funds tracked by Wall St. Rank hold EXAS as of Q2 2018.

  • PEAK6 Group reported no remaining Exact Sciences position as of Q2 2018 after selling out during the quarter.
  • PEAK6 Group sold 16,985 Exact Sciences shares in Q2 2018, an estimated $914K.
  • PEAK6 Group first reported a position in Exact Sciences in Q4 2017 and held it in 2 quarters.
  • PEAK6 Group's Exact Sciences position peaked at $685K in Q1 2018.
  • 348 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2018.

Based on PEAK6 Group's 13F filing for Q2 2018, filed 15 Aug 2018.